Articles Referencing VRTX
Vertex Loss Lower, Kalydeco Outlook Up - Analyst Blog
5/1/2013, 8:49 am from Zacks.com in Investing, Business, Stocks
Vertex Pharmaceuticals Inc. ( VRTX ) posted a loss
of 12 cents per share (including stock-based compensation expense)
in the first quarter of 2013, well below the year-ago earnings of
41... Read >>
Benzinga Market Primer: Wednesday, May 1
5/1/2013, 6:37 am from Benzinga in Investing, Bonds, Commodities, Futures, International
Futures Higher Ahead of Key Economic Data, Earnings U.S. equity futures rose in early pre-market trade ahead of key
earnings and economic data. The FOMC rate decision and policy
statement is due... Read >>
After-Hours Earnings Report for April 30, 2013 : EQR, VRTX, AVB, BXP, FISV, OKE, VRSK, AUY, FMC, WU, OKS, TRMB
4/30/2013, 2:00 pm from NASDAQ.com News in News Headlines, Earnings
The following companies are expected to report earnings after
hours on 04/30/2013. Visit our Earnings
Calendar for a full list of expected earnings releases. Equity Residential ( EQR ) is... Read >>
Benzinga Market Primer: Tuesday, April 30
4/30/2013, 6:38 am from Benzinga in Investing, Bonds, Commodities, Futures, International
Futures Flat on Mixed Economic Data U.S. equity futures traded little changed in early pre-market
trade following mixed global economic data. Mixed data out of Japan
was followed by a flood of... Read >>
Merck - BMY in HCV Deal - Analyst Blog
4/23/2013, 6:09 pm from Zacks.com in Investing, Business, Stocks
Merck & Co. Inc. ( MRK ) recently joined
forces with Bristol-Myers Squibb (BMY) to conduct a phase II study
with their hepatitis C virus (HCV) candidates. The study will
evaluate... Read >>
FDA Approves Novartis' Simbrinza - Analyst Blog
4/22/2013, 6:12 pm from Zacks.com in Investing, Business, Stocks
Novartis ( NVS ) recently
announced that the US Food and Drug Administration (FDA) has
approved Simbrinza Suspension for the reduction of elevated
intraocular pressure (IOP) in patients... Read >>
Merck In-Licenses from Xenon - Analyst Blog
4/22/2013, 6:11 pm from Zacks.com in Investing, Business, Stocks
Merck & Co. Inc. ( MRK ) recently
announced the in-licensing of Xenon Pharmaceuticals Inc.'s small
molecule compounds for a novel target to treat cardiovascular
disease. Merck and... Read >>
Market Close Report: NASDAQ Composite index closes at 3,233.55 up 27.49 points
4/22/2013, 4:45 pm from NASDAQ.com News in News Headlines, US Markets
Monday's session closes with the NASDAQ Composite Index at
3,233.55. The total shares traded for the NASDAQ was over 1.6
billion. Advancers stocks led declining by 1.08 to 1 ratio. There... Read >>
Market Close Report: NASDAQ Composite index closes at 3,206.06 up 39.70 points
4/19/2013, 4:45 pm from NASDAQ.com News in News Headlines, US Markets
Friday's session closes with the NASDAQ Composite Index at
3,206.06. The total shares traded for the NASDAQ was over 1.68
billion. Advancers stocks led declining by 2.11 to 1 ratio. There... Read >>
PSTI Plans to Start Phase I Study - Analyst Blog
4/19/2013, 4:11 pm from Zacks.com in Investing, Business, Stocks
Pluristem Therapeutics Inc. ( PSTI ) recently
announced its intention to commence a phase I study that will
evaluate the safety and efficacy of the local administration of
PLacental... Read >>
BMY, Santaris Pharma Team Up - Analyst Blog
4/19/2013, 4:10 pm from Zacks.com in Investing, Business, Stocks
Bristol-Myers Squibb Co. ( BMY ) recently entered
into a strategic alliance with privately-held biopharmaceutical
company Santaris Pharma A/S to discover and develop medicines on a
global... Read >>
Vertex CF Candidate Impresses - Analyst Blog
4/19/2013, 3:40 pm from Zacks.com in Investing, Business, Stocks
Vertex Pharmaceuticals Incorporated ( VRTX ) received a huge
boost with the company reporting impressive phase II data on its
cystic fibrosis (CF) candidate, VX-661. The randomized,... Read >>
Mid-Day Market Update: Celanese Jumps On Upbeat Results, Rambus Declines
4/19/2013, 1:16 pm from Benzinga in Investing, Commodities, Economy, International
Midway through trading Friday, the Dow traded down 0.08 percent
to 14,525.77 while the NASDAQ gained 1.19 percent to 3,204.18. The
S&P also rose, gaining 0.72 percent to 1,552.66. ... Read >>
Mid-Morning Market Update: Markets Mixed, General Electric Q1 Profit Surges 16%
4/19/2013, 10:02 am from Benzinga in Investing, Commodities, Economy, International
Following the market opening Friday, the Dow traded down 0.40
percent to 14,478.60 while the NASDAQ gained 0.21 percent to
3,172.88. The S&P also rose, gaining 0.16 percent to
1,544.10.... Read >>
Pre-Market Most Active for Apr 19, 2013 : DELL, GE, VOD, QQQ, TOT, MSFT, BAC, VRTX, SAP, NOK, BIOS, DEO
4/19/2013, 8:39 am from NASDAQ.com News in News Headlines, Pre-market Most Active
The NASDAQ 100
Pre-Market Indicator is up 16.35 to 2,758.3. The total
Pre-Market volume is currently 12,552,022 shares traded.
The following are the
most active stocks for the pre-market... Read >>